SUWN.OB

[nmbr1ballr]

What do you guys still think of this stock?  I just put in a buy order at the bid price of .215 for 6976 shares ($1,500).  So far it has yet to be filled.

[wrangler]

Hi nmbr1ballr
You might want to check you're buy order if it's not being filled. Scottrade will not do order under 1.00 unless it's a limit order. Don't know you're broker but you might want to check that.

[nmbr1ballr]

Ya I know.  I use ameritrade and had it as a limit order.  They just didn't want to sell so I canceled that order and replaced it with the ask price of .22 and was filled in just a few minutes.  So I now own 6818 shares @ .22. 

[nmbr1ballr]

Already more volume before 11:00 then all day yesterday.  Up 8% so far.   

[higherstocks]

Ive seen enough.  Im In 

[vic666]

here's chart for today...so far. pretty bullish. more vol. will add some fire.

will it take out 0.26? only time will tell.

[vic666]

nothing really changed since my last post....tested 0.26 a few times. break of that will take this to 0.30, the most recent and the 52 week high.

if that's taken out, clear coasting to 0.50 IMO. 

Merry Christmas and a Happy New Year 2006 to everybody on this excellent 3SOF board.

[nmbr1ballr]

SUWN is up 20% at the moment.  Was up a lil higher earlier.  Already 2.2 million shares traded in the first 40 minutes.  No news either, hmm...

[nmbr1ballr]

Stock is doing very good recently.  How high do you think it can go?
http://stockcharts.com/def/servlet/SC.web?c=suwn

[dhiraj19]

Looking at stocks such as SQUM, XSNX and BRVO history, this may go to same levels of 0.7 before coming down. Technically volume is average and stock price is up. good signs... there are so many technical gurus here, would like to see their take on it.

- Dhiraj

[wrangler]

This may explain why this stock is so hot

Press Release Source: Sunwin International Neutraceuticals, Inc.

WallStreet Research Continues Coverage of Sunwin International Neutraceuticals Inc. Shares With Speculative Strong Buy Recommendation at www.WallStreetResearch.org
Wednesday January 4, 10:55 am ET

NEW YORK, NY--(MARKET WIRE)--Jan 4, 2006 -- WallStreet Research, a prominent equity research boutique led by Alan Stone, Managing Director of Alan Stone & Company, LLC, announced today that it has released an update report continuing coverage with a speculative strong buy recommendation of Sunwin International Neutraceuticals, Inc. (OTC BB:SUWN.OB - News), a diversified global nutraceutical company. The complete analyst research report, together with the risks associated therewith and additional information about WallStreet Research, is available at www.WallStreetResearch.org.

Mr. Stone was formerly a securities analyst and assistant portfolio manager at Merrill Lynch Asset Management and an investment analyst at Prudential Insurance Company's Capital Markets Group. WallStreet Research specializes in the microcap and smallcap investment arena, looking for emerging growth companies with strong management, unique or proprietary technology products, significant market potential, financial strength, and outstanding long-term earnings growth possibilities. The firm has offices in Los Angeles, CA; Palm Beach, FL; and New York City, NY, and is well known for discovering undervalued companies and bringing them to the attention of the investment community.

Sunwin International Neutraceuticals, Inc. (www.sunwin.biz), headquartered in Qufu, in the Shandong Province of the People's Republic of China, is a diversified nutraceutical company engaged in the development, manufacturing and international sale of a variety of health products for humans and animals. The Company's agricultural processing expertise and convenient access to raw materials in select Chinese farmlands result in high-quality and cost-effective natural products that straddle the healthcare industry and the food & beverage marketplace. Products offered by the Company include a powerful low-calorie natural sweetener called stevioside, numerous herbal extracts rooted in traditional Chinese medicine (TCM), as well as a variety of veterinary medicines and feed supplements. Their innovative nature has in recent years earned state-level recognition and several industry awards for the Company. For the fiscal year ended April 30, 2005, the Company's revenues rose 11.3% to $12.1 million, and the net income increased 78% to $829,114, or $.02 per share. In the first six months of fiscal 2006 ended October 31, 2005, total revenues climbed 11.8% to $7,223,971, from $6,458,285 in comparable period in the previous year. Last September, the Company completed an upgrade and expansion of most of its manufacturing facilities, which not only increased stevioside production capacity to 300 tons per year, or a double-digit percentage share of the global demand, but also fulfilled GMP requirements mandated since the beginning of 2006 by the central government on producers of Chinese herb and veterinary medicines. Trading on the OTC Bulletin Board under the symbol SUWN, the Company is well positioned to immediately capitalize on the temporary competitive advantage resulting from the GMP certification and benefit from the overall growing health concerns among consumers globally, increasing popularity of organic foods and medicines, and the strong condition of the Chinese economy.

[nmbr1ballr]

That was released Jan. 4th.  Why the jump 2 weeks later after it came out?

[wrangler]

I had to use above chart to show my reason for move in stock, I'm not saying this is the main reason why stock is moving but chart showed it was heading in an upward trend
Goodluck trading









































































i

[nmbr1ballr]

Well Im not exactly how sure how to read charts besides things like volume.  Its up another 13%. 
I am up about 115% since I invested.  Only wish I put in more.

[gmarc66]

I had been holding it for awhile and forgot i had at gtc sell order at .41, so it accidentally sold yesterday and couldn't cancel it in time....still made a profit, but would have been great to more than double it. 

Is it still going higher? ]

I like your chart analysis style Wrangler

Glta

julia